Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000886916 | SCV001030445 | benign | Glycogen storage disease IXa1 | 2023-07-20 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000886916 | SCV002807838 | likely benign | Glycogen storage disease IXa1 | 2022-01-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002539357 | SCV003557974 | likely benign | Inborn genetic diseases | 2021-09-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV003438557 | SCV004166677 | likely benign | not provided | 2023-04-01 | criteria provided, single submitter | clinical testing | PHKA2: BS2 |